Thursday, 24 March 2022

Moderna seeks approval for COVID-19 vaccine in young children

After months of stops and starts, Moderna announced today it seeks emergency use authorization from the Food and Drug Administration (FDA) of a two-dose primary series of its COVID-19 vaccine for children ages 6 months to 6 years.


Continue Reading...

No comments:

Post a Comment